Comorbidities as an indication for metabolic surgery
Metabolic diseases, comprising type 2 diabetes mellitus (T2DM), dyslipidemia, and non-alcoholic steatohepatitis (NASH), are rapidly increasing worldwide. Conservative medical therapy, including the newly available drugs, has only limited effects and does neither influence survival or the development...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
September 28, 2018
|
| In: |
Visceral medicine
Year: 2018, Jahrgang: 34, Heft: 5, Pages: 381-387 |
| ISSN: | 2297-475X |
| DOI: | 10.1159/000493291 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1159/000493291 Verlag, Volltext: https://www.karger.com/Article/FullText/493291 
|
| Verfasserangaben: | Anne-Catherine Schwarz, Adrian T. Billeter, Katharina M. Scheurlen, Matthias Blüher, Beat P. Müller-Stich |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1675726396 | ||
| 003 | DE-627 | ||
| 005 | 20220816220255.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190903s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1159/000493291 |2 doi | |
| 035 | |a (DE-627)1675726396 | ||
| 035 | |a (DE-599)KXP1675726396 | ||
| 035 | |a (OCoLC)1341242488 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schwarz, Anne-Catherine |d 1990- |e VerfasserIn |0 (DE-588)1167263316 |0 (DE-627)1030929203 |0 (DE-576)511060955 |4 aut | |
| 245 | 1 | 0 | |a Comorbidities as an indication for metabolic surgery |c Anne-Catherine Schwarz, Adrian T. Billeter, Katharina M. Scheurlen, Matthias Blüher, Beat P. Müller-Stich |
| 264 | 1 | |c September 28, 2018 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 03.09.2019 | ||
| 520 | |a Metabolic diseases, comprising type 2 diabetes mellitus (T2DM), dyslipidemia, and non-alcoholic steatohepatitis (NASH), are rapidly increasing worldwide. Conservative medical therapy, including the newly available drugs, has only limited effects and does neither influence survival or the development of micro- or macrovascular complications, nor the progression of NASH to liver cirrhosis, nor the development of hepatocellular carcinomas in the NASH liver. In contrast, metabolic surgery is very effective independent of the preoperative body mass index (BMI) in reducing overall and cardiovascular mortality in patients with T2DM. Furthermore, metabolic surgery significantly reduces the development of micro- and macrovascular complications while being the most effective therapy in order to achieve remission of T2DM and to reach the targeted glycemic control. Importantly, even existing diabetic complications such as nephropathy as well as the features of NASH can be reversed by metabolic surgery. Here, we propose indications for metabolic surgery due to T2DM and NASH based on a simple but objective, disease-specific staging system. We outline the use of the Edmonton Obesity Staging System (EOSS) as a clinical staging system independent of the BMI that will identify patients who will benefit the most from metabolic surgery. | ||
| 700 | 1 | |a Billeter, Adrian |d 1984- |e VerfasserIn |0 (DE-588)1071497499 |0 (DE-627)825950732 |0 (DE-576)433113804 |4 aut | |
| 700 | 1 | |a Scheurlen, Katharina |d 1989- |e VerfasserIn |0 (DE-588)1072528525 |0 (DE-627)82768892X |0 (DE-576)434005061 |4 aut | |
| 700 | 1 | |a Blüher, Matthias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Müller, Beat P. |d 1971- |e VerfasserIn |0 (DE-588)14066209X |0 (DE-627)70374819X |0 (DE-576)317992287 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Visceral medicine |d Basel : Karger, 2016 |g 34(2018), 5, Seite 381-387 |h Online-Ressource |w (DE-627)853903220 |w (DE-600)2850734-4 |w (DE-576)462791696 |x 2297-475X |7 nnas |a Comorbidities as an indication for metabolic surgery |
| 773 | 1 | 8 | |g volume:34 |g year:2018 |g number:5 |g pages:381-387 |g extent:7 |a Comorbidities as an indication for metabolic surgery |
| 856 | 4 | 0 | |u https://doi.org/10.1159/000493291 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://www.karger.com/Article/FullText/493291 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190903 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 14066209X |a Müller, Beat P. |m 14066209X:Müller, Beat P. |d 910000 |d 910200 |e 910000PM14066209X |e 910200PM14066209X |k 0/910000/ |k 1/910000/910200/ |p 5 |y j | ||
| 998 | |g 1072528525 |a Scheurlen, Katharina |m 1072528525:Scheurlen, Katharina |d 910000 |d 910200 |e 910000PS1072528525 |e 910200PS1072528525 |k 0/910000/ |k 1/910000/910200/ |p 3 | ||
| 998 | |g 1071497499 |a Billeter, Adrian |m 1071497499:Billeter, Adrian |d 910000 |d 910200 |e 910000PB1071497499 |e 910200PB1071497499 |k 0/910000/ |k 1/910000/910200/ |p 2 | ||
| 998 | |g 1167263316 |a Schwarz, Anne-Catherine |m 1167263316:Schwarz, Anne-Catherine |d 910000 |d 910200 |e 910000PS1167263316 |e 910200PS1167263316 |k 0/910000/ |k 1/910000/910200/ |p 1 |x j | ||
| 999 | |a KXP-PPN1675726396 |e 3511226511 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"title":[{"title_sort":"Comorbidities as an indication for metabolic surgery","title":"Comorbidities as an indication for metabolic surgery"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"September 28, 2018","dateIssuedKey":"2018"}],"recId":"1675726396","relHost":[{"pubHistory":["Vol. 32, issue 1 (February 2016)-"],"part":{"issue":"5","pages":"381-387","extent":"7","volume":"34","text":"34(2018), 5, Seite 381-387","year":"2018"},"language":["eng"],"title":[{"title_sort":"Visceral medicine","subtitle":"gastroenterology, endoscopy and surgery - the interdisciplinary approach to gastrointestinal disease","title":"Visceral medicine"}],"note":["Gesehen am 12.04.2019"],"disp":"Comorbidities as an indication for metabolic surgeryVisceral medicine","id":{"eki":["853903220"],"issn":["2297-475X"],"zdb":["2850734-4"]},"physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"Visc Med"}],"origin":[{"publisherPlace":"Basel","publisher":"Karger","dateIssuedDisp":"2016-","dateIssuedKey":"2016"}],"recId":"853903220"}],"note":["Gesehen am 03.09.2019"],"id":{"eki":["1675726396"],"doi":["10.1159/000493291"]},"physDesc":[{"extent":"7 S."}],"name":{"displayForm":["Anne-Catherine Schwarz, Adrian T. Billeter, Katharina M. Scheurlen, Matthias Blüher, Beat P. Müller-Stich"]},"person":[{"display":"Schwarz, Anne-Catherine","given":"Anne-Catherine","role":"aut","family":"Schwarz"},{"display":"Billeter, Adrian","role":"aut","given":"Adrian","family":"Billeter"},{"display":"Scheurlen, Katharina","given":"Katharina","role":"aut","family":"Scheurlen"},{"family":"Blüher","display":"Blüher, Matthias","given":"Matthias","role":"aut"},{"family":"Müller","given":"Beat P.","role":"aut","display":"Müller, Beat P."}]} | ||
| SRT | |a SCHWARZANNCOMORBIDIT2820 | ||